BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38172714)

  • 1. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
    Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
    Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.
    Miao Y; Chen X; Qin M; Zhou W; Wang Y; Ji Y
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34698360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
    Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
    Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A.
    Sun S; Wang H; Ji M
    Technol Cancer Res Treat; 2019; 18():1533033819892256. PubMed ID: 31829105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
    Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
    Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
    Brady G; Whiteman HJ; Spender LC; Farrell PJ
    J Virol; 2009 Jul; 83(13):6909-16. PubMed ID: 19403666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo.
    Hong M; He J; Li D; Chu Y; Pu J; Tong Q; Joshi HC; Tang S; Li S
    J Exp Clin Cancer Res; 2020 Mar; 39(1):52. PubMed ID: 32197643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
    Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
    Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
    Wang HT; Tong X; Zhang ZX; Sun YY; Yan W; Xu ZM; Fu WN
    FEBS J; 2019 Oct; 286(19):3892-3908. PubMed ID: 31152622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
    She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
    Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
    Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
    Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
    PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo.
    Xu G; Wang H; Yuan D; Yao J; Meng L; Li K; Zhang Y; Dang C; Zhu K
    Clin Transl Oncol; 2020 Oct; 22(10):1762-1777. PubMed ID: 32239427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1 Regulates a Transcription Program That Affects the Dynamics of Cell Cycle Entry of Naive Resting B Cells.
    Thomsen I; Kunowska N; de Souza R; Moody AM; Crawford G; Wang YF; Khadayate S; Whilding C; Strid J; Karimi MM; Barr AR; Dillon N; Sabbattini P
    J Immunol; 2021 Dec; 207(12):2976-2991. PubMed ID: 34810221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.